Weekly Roundup: AMD Rises, Western Alliance & Zion Drop, Gold Miners Rally Falters
On this episode of Stock Movers, we take a look at some of the week's biggest movers: - AMD (AMD) landed a major order from Oracle for its forthcoming MI450 chips, a sign it’s making headway in its pursuit of Nvidia Corp. in the booming market for AI processors. Oracle will put 50,000 of the semiconductors in data center computers starting in the third quarter of 2026, according to a statement Tuesday. The systems will contain AMD processors and networking components. It’s also another endorsement of AMD technology. The Santa Clara, California-based company is working to become a credible alternative to Nvidia, the dominant provider of AI processors. Shares of the chipmaker rose as much as 4% in New York on Monday. - US bank stocks stabilized Friday as a new set of earnings from regional lenders was solid, helping ease concerns over credit quality that sparked a sharp selloff. The S&P Regional Banks Select Industry Index jumped 1.7% Friday, with Zions Bancorp (ZION) and Truist Financial Corp among the top performers. The modest rebound follows a 6.3% plunge on Thursday, led by Zions and Western Alliance Bancorp (WAL) after they said they were victims of fraud on loans to funds that invest in distressed commercial mortgages. - Gold’s rally has awed Wall Street for months. Gold miners have done even better - so well that investors are now asking whether historic gains in shares of Newmont (NEM) Agnico Eagle Mines (AEM) and their competitors have gone too far. The NYSE Arca Gold Miners Index (GDM) was down 6% at 4:10 p.m. in New York on Friday, the biggest drop since May, while bullion fell more than 2%. Newmont sank 7.6%, Agnico Eagle Mines slid 6% and Barrick Mining Corp. retreated 6.5%. The trio had each enjoyed gains of more than 100% this year, while gold gained just over 60%.See omnystudio.com/listener for privacy information.
-------- Â
5:15
--------
5:15
Closing Bell: Regional Banks Rebound, American Express Surges, Oracle Falls
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Bailey Lipshultz and Carol Massar.On this episode of Stock Movers:- Truist Financial (TFC) shares rise after the firm told investors during its earnings conference call that while the bank had no exposure to bankrupt Tricolor Holdings, it has some exposure to First Brands. The bank accounted for this in its non-performing loans, loan loss reserve and 2025 net charge-off guidance, per CFO Mike Maguire.- American Express (AXP) reported earnings that beat expectations after unveiling the long-anticipated Platinum credit card refresh last month. Initial demand for the revamped Platinum card exceeded the firm’s predictions, with US Platinum account acquisitions doubling from pre-refresh levels. The firm raised the lower end of its full-year guidance, with revenue now expected to grow 9% to 10% and earnings likely to total $15.20 to $15.50 a share.- Oracle (ORCL) fell after giving its long-range financial outlook, suggesting investors anticipated a bigger boost from its investment in AI infrastructure. The company said overall annual revenue would total $225 billion by fiscal 2030, and the cloud infrastructure business would produce $144 billion in sales by then. Investors have expressed concern about the profitability of Oracle's AI effort, but the company said an infrastructure project for AI would have a gross margin of 35%.See omnystudio.com/listener for privacy information.
-------- Â
4:52
--------
4:52
Oracle Falls, American Express Surges, Eli Lilly Falls on 'Cheap Weight Loss Dugs'
On this episode of Stock Movers:- Oracle (ORCL) fell after giving its long-range financial outlook, suggesting investors anticipated a bigger boost from its investment in AI infrastructure. The company said overall annual revenue would total $225 billion by fiscal 2030, and the cloud infrastructure business would produce $144 billion in sales by then. Investors have expressed concern about the profitability of Oracle's AI effort, but the company said an infrastructure project for AI would have a gross margin of 35%.- American Express (AXP) reported earnings that beat expectations after unveiling the long-anticipated Platinum credit card refresh last month. Initial demand for the revamped Platinum card exceeded the firm’s predictions, with US Platinum account acquisitions doubling from pre-refresh levels. The firm raised the lower end of its full-year guidance, with revenue now expected to grow 9% to 10% and earnings likely to total $15.20 to $15.50 a share.- Eli Lilly (LLY) and Novo Nordisk shares fell after President Donald Trump said the price of the diabetes drug Ozempic could come down to just $150 a month. Trump told reporters that the cost of the drug will soon be “much lower” than the current US list price of roughly $1,000 for a month’s supply. The potential price cut could lead to a big hit for Novo and Lilly, which dominate a market expected to top $95 billion by 2030See omnystudio.com/listener for privacy information.
-------- Â
5:04
--------
5:04
Truist Financial Rises, Micron Falls, Novo Nordisk Slides After Trump Touts Lower Ozempic Price
On this episode of Stock Movers:- Truist Financial (TFC) shares rise after the firm told investors during its earnings conference call that while the bank had no exposure to bankrupt Tricolor Holdings, it has some exposure to First Brands. The bank accounted for this in its non-performing loans, loan loss reserve and 2025 net charge-off guidance, per CFO Mike Maguire. - Micron (MU) shares falls after a report from Reuters that the chipmaker plans to stop supplying server chips to data centers in China after the business failed to recover from a 2023 government ban on its products in critical Chinese infrastructure. - Novo Nordisk (NOVO) shares slide after President Donald Trump said the price of the diabetes drug Ozempic could come down to just $150 a month. Talks over the price of weight-loss drugs, including Ozempic, are still ongoing, according to Mehmet Oz, head of the Centers for Medicare and Medicaid Services.See omnystudio.com/listener for privacy information.
-------- Â
4:02
--------
4:02
Novo Nordisk Falls, State Street Drops, Zions Plunges on Losses From Alleged Fraud On this episode of Stock Movers:
On this episode of Stock Movers:- Novo Nordisk (NOVO) shares fall after President Donald Trump said the price of the diabetes drug Ozempic could come down to just $150 a month. Talks over the price of weight-loss drugs, including Ozempic, are still ongoing, according to Mehmet Oz, head of the Centers for Medicare and Medicaid Services.- State Street (STT) shares drop after the financial manager’s net interest income fell short of expectations in the third quarter. The company’s adjusted earnings per share for the quarter that beat the average analyst estimate.- Zion (ZION) shares plunge along with Western Alliance after the companies said they were victims of fraud on loans to funds that invest in distressed commercial mortgages. The disclosures add to other recent loan blowups, including subprime auto lender Tricolor Holdings and auto-parts supplier First Brands Group, which triggered losses for some banks.See omnystudio.com/listener for privacy information.
Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.
Ireland